Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease

NCT04984330 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Funding withdrawn

Conditions

Interventions

Sponsor

Weill Medical College of Cornell University

Collaborators